Sleep Onset Insomnia Therapeutics
1. Rozerem patent expiration
Treatment: Method of treating a biological rhythm disorder, such as insomnia; Method of treating insomnia characterized by difficulty with sleep onset
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10098866 | TAKEDA PHARMS USA | Pharmaceutical preparation containing copolyvidone |
Nov, 2021
(4 years ago) | |
| US6034239 | TAKEDA PHARMS USA | Tricyclic compounds, their production and use |
Jul, 2019
(6 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-82) | Oct 20, 2011 |
Drugs and Companies using RAMELTEON ingredient
Market Authorisation Date: 22 July, 2005
Dosage: TABLET
How can I launch a generic of ROZEREM before it's drug patent expiration?
More Information on Dosage
ROZEREM family patents
